SCHEMBL26319532

SCHEMBL26319532

CC(C)(C)OC(=O)N[C@H]1CC[C@H](n2ccccc2=O)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 5/20 0.51
▸ KDM1A O60341 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ KMT2A Q03164 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ JAK1 P23458 4/20 0.48
▸ NAMPT P43490 1/20 0.47
▸ KCNA3 P22001 1/20 0.47
▸ CKS1B P61024 1/20 0.47
▸ SKP1 P63208 1/20 0.47
▸ SKP2 Q13309 1/20 0.47
▸ EPHX2 P34913 1/20 0.45
▸ DRD3 P35462 1/20 0.44
▸ OPRM1 P35372 1/20 0.44
▸ OPRD1 P41143 1/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ OGFRL1 Q5TC84 1/20 0.44
▸ JAK2 O60674 1/20 0.43
▸ PIM1 P11309 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30531972 1.00 DRD2 (0.51) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL4627783 0.79 KDM1A (0.52) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL4814305 0.79 KDM1A (0.52) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL3865823 0.78 KDM1A (0.52) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL14334645 0.78 GPR119 (0.59) NAMPT
SCHEMBL17830852 0.76 CKS1B (0.61) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL13999223 0.76 KDM1A (0.58) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL30201369 0.75 KMT2A (0.61) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL12794285 0.75 CTSK (0.52) DRD2KDM1AMAOBKMT2AL3MBTL1
SCHEMBL12794288 0.75 CTSK (0.52) DRD2KDM1AMAOBKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023152349-A1 IRAK4 INHIBITORS ASTRAZENECA AB (SE) 2023-08-17 — — WO disclosed
Send feedback